Australian Centre for Artifical Intelligence in Medical Innovation (ACAMI)
The world’s first university innovation centre specialising in the application of artificial intelligence to accelerate the discovery and development of immunotherapies, vaccines and medical innovation
OUR KEY AREAS
The intersection of AI and medical innovation
BioNTech calls La Trobe home
La Trobe University is home to global biotechnology company BioNTech’s state-of-the-art mRNA clinical-scale manufacturing facility at the Melbourne campus in Bundoora, in an agreement facilitated by the Victorian Government. The facility will support researchers to develop investigational mRNA-based treatment options, as well as manufacture investigational candidates for clinical trials in the Asia-Pacific region.
La Trobe is already a world leader in AI and digital innovation. The Australian Centre for AI in Medical Innovation will greatly accelerate the process of translating medical breakthroughs into cost-effective and widely-accessible, personalised cancer vaccines and treatments.
The planned BioNTech facility will establish La Trobe as a centre of a new mRNA technology, providing access not only to its own researchers but also access to collaborators from across Australia and the world.
IN PARTNERSHIP
ACAMI was established through the support of the Victorian Government through mRNA Victoria.
Connect with us
News
-
Researchers awarded in latest DECRA scheme funding round
La Trobe University researchers have secured more than $800,000 in Australian Government funding as part of the Australian Research Council Discovery Early Career Research Award (DECRA) scheme.
-
-
Ballet partnership explores works of Oscar Wilde
La Trobe, The Australian Ballet explore the works of Oscar Wilde
Events
No upcoming events at the moment. Check back soon.